Cary, NC 9/24/10—SciQuest completed its IPO on the NASDAQ stock exchange (see IBO 3/31/10) on September 24. The company offered six million shares of its common stock at $9.50 per share. Underwriters were granted the option to purchase up to an additional 900,000 shares by certain selling stockholders. SciQuest provides on-demand software for strategic procurement […]
Second-quarter 2010 IBO Life Science Index sales improved 8.3% to $2,835.24 million, including a loss of 0.2% from currency. Operating profit jumped 20.0% to $647.97 million, and operating margin climbed 230 basis points to 22.9% of sales. Second-quarter sales for Beckman Coulter’s Life Science segment declined 2.1%, 3.2% excluding currency, to $106.5 million (see page […]
Rockville, MD and Seoul, South Korea 9/13/11—Seegene has raised $16.6 million through an offering of 636,500 shares on the KOSDAQ, the Korean Stock Exchange. Seegene provides PCR technology for molecular diagnostics and research applications. “Our products are defining a new category of molecular diagnostics that are capable of simultaneously detecting multiple pathogens or genetic mutations […]
Sales of analytical instruments for security and safety are continuing to grow steadily. One important facet of this market is bio-based detection, which consists of two primary segments: nucleic acid amplification, commonly known as polymerase chain reaction (PCR), and other biochemical technologies. The information comes from the Strategic Directions International report “Chasing Disaster: Analytical Instrumentation […]
As with most business sectors, lab and inspection companies’ revenues suffered in 2009 as the economic crisis hurt testing volumes and revenue growth. According to IBO’s examination of the results of five of the largest publicly held contract testing companies, revenues are improving this year as business returns to normal. In aggregate, these firms operate […]
In August, economic worries sent the Dow Jones Industrial Average down 4.3% and into negative territory for the year. The S&P 500 and NASDAQ contracted 4.7% and 6.2% for the month, respectively. Even with improved capital spending and strong corporate earnings, the unemployment rate and a slowing global economy remained major contentions. The unemployment rate […]
Instrument and laboratory product sales continued to gain strength in the second quarter of calendar year 2010, according to sales results for the nine major publicly listed instrument and lab product companies discussed on pages 9–11. The quarter provided further evidence of a general recovery for instrument demand. However, most companies remained cautious due to […]
In the second quarter of 2010, revenues for IBO’s Laboratory Sales Index grew 9.5% to $5,198.02 million, including a loss of 3.9% from currency. Operating profit jumped 18.3% to $1,009.63 million, while operating margin improved 140 basis points to 19.4% of sales. For the three companies (Oxford Instruments, Shimadzu and Spectris) that did not report […]
Brea, CA 7/22/10—On its conference call discussing second-quarter results, Beckman Coulter announced that it has reduced its outlook for 2010 Life Sciences revenues by $30–$40 million. The company stated it has revised its expectations for the business due to less-than-expected stimulus-related sales and reduced spending by pharmaceutical companies due to consolidation activities. The revised outlook […]
Company Announcements IDBS entered into a strategic partnership with Soluzioni Informatiche for distribution of its E-Workbook Suite in Italy. TIBCO Software partnered with IDBS to integrate their respective Spotfire Analytics Platform and ActivityBase chemistry technology for exploring the extended effects of chemical structures on biological activity. Bio-IT World reported in April that Microsoft spun off […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
